S-1 JournalJul 29, 2026
It Didn’t Invent the Drug. It Didn’t Run the Trials. It In-Licensed the Rest-of-World Rights.
S-1 JournalJul 23, 2026
It Paid Out $90 Million. Eight Days Later, It Filed an S-1.
S-1 JournalJul 19, 2026
Scoreboard — If you had invested $1,000 on IPO day
S-1 JournalJul 19, 2026
It Powers 99% of Phones, Yet Its Own Listing Pays It Nothing
S-1 JournalJul 13, 2026
The Primary Endpoint Was Met. What the FDA Questioned Was Its “Meaning.”
S-1 JournalJul 13, 2026
Nearly 40 Years in Nuclear. Next: Two Unproven Bets.
S-1 JournalJul 10, 2026
It Calls Itself an Edge-AI Company. About 95% of Its Revenue Is Microphones.
S-1 JournalJul 9, 2026
The Shop a 17-Year-Old Bought. Filed for IPO by PE in 18 Months.
S-1 JournalJul 6, 2026
Lime went public still held by Uber’s six strings